Disseminated tumour cells in bone marrow of patients with uveal melanoma

Acta Ophthalmologica

Volumn 91, Issue 4, 2013, Pages 343-348

  Eide, Nils ^a   Hoifødt, Hanne K ^a,b   Nesland, Jahn M ^a   Faye, Ragnar S ^a,b   Qvale, Geir A ^a   Faber, Rowan T ^a   Jebsen, Peter ^a   Kvalheim, Gunnar ^b   Fodstad, Øystein ^a,b  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

bone marrow; disseminated tumour cells micrometastasis; immunocytochemistry; immunomagnetic selection outcome; uveal melanoma

Indexed keywords

MONOCLONAL ANTIBODY HMB 45;

ADOLESCENT; ADULT; AGED; ARTICLE; BONE MARROW METASTASIS; CANCER MORTALITY; CHILD; CONTROLLED STUDY; DEATH; FEMALE; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IMMUNOMAGNETIC SEPARATION; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MELANOMA CELL; MICROSCOPY; MONONUCLEAR CELL; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; SCHOOL CHILD; SENSITIVITY ANALYSIS; UVEA MELANOMA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BONE MARROW CELLS; BONE MARROW NEOPLASMS; CHILD; DIAGNOSIS, DIFFERENTIAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; INCIDENCE; MALE; MELANOMA; MIDDLE AGED; NEOPLASTIC CELLS, CIRCULATING; NORWAY; RETROSPECTIVE STUDIES; SURVIVAL RATE; TIME FACTORS; UVEAL NEOPLASMS; YOUNG ADULT;

EID: 84878450732     PISSN: 1755375X     EISSN: 17553768     Source Type: Journal    
DOI: 10.1111/j.1755-3768.2012.02449.x     Document Type: Article

References (21)

1. Benez A, Geiselhart A, Handgretinger R, Schiebel U, &, Fierlbeck G, (1999): Detection of circulating melanoma cells by immunomagnetic cell sorting. J Clin Lab Anal 13: 229-233.
2. Callejo SA, Antecka E, Blanco PL, Edelstein C, &, Burnier MN Jr, (2007): Identification of circulating malignant cells and its correlation with prognostic factors and treatment in uveal melanoma. A prospective longitudinal study. Eye (Lond) 21: 752-759.
3. Diener-West M, Hawkins BS, Markowitz JA, &, Schachat AP, (1992): A review of mortality from choroidal melanoma. II. A meta-analysis of 5-year mortality rates following enucleation, 1966 through 1988. Arch Ophthalmol 110: 245-250.
4. Eide N, Faye RS, Hoifodt HK, Overgaard R, Jebsen P, Kvalheim G, &, Fodstad O, (2009): Immunomagnetic detection of micrometastatic cells in bone marrow in uveal melanoma patients. Acta Ophthalmol 87: 830-836.
5. Eide N, Overgaard R, Jebsen P, Qvale G, Faye RS, Hoifodt HK, Kvalheim G, &, Fodstad O, (2010): The paradox of bone marrow micrometastases in uveal melanoma, a comparison of the bone marrow test results and survival. XXVIIth Meeting of the Club Jules GoninP7.
6. Eskelin S, Pyrhonen S, Summanen P, Hahka-Kemppinen M, &, Kivela T, (2000): Tumor doubling times in metastatic malignant melanoma of the uvea: tumor progression before and after treatment. Ophthalmology 107: 1443-1449.
7. Flatmark K, Bjornland K, Johannessen HO, et al., (2002): Immunomagnetic detection of micrometastatic cells in bone marrow of colorectal cancer patients. Clin Cancer Res 8: 444-449.
8. Flatmark K, Borgen E, Nesland JM, et al., (2011): Disseminated tumour cells as a prognostic biomarker in colorectal cancer. Br J Cancer 104: 1434-1439.
9. Kikuchi A, Shimizu H, &, Nishikawa T, (1996): Expression and ultrastructural localization of HMB-45 antigen. Br J Dermatol 135: 400-405.
10. Kitago M, Koyanagi K, Nakamura T, et al., (2009): mRNA expression and BRAF mutation in circulating melanoma cells isolated from peripheral blood with high molecular weight melanoma-associated antigen-specific monoclonal antibody beads. Clin Chem 55: 757-764.
11. Kivela T, Eskelin S, &, Kujala E, (2006): Metastatic uveal melanoma. Int Ophthalmol Clin 46: 133-149.
12. Li Y, Madigan MC, Lai K, Conway RM, Billson FA, Crouch R, &, Allen BJ, (2003): Human uveal melanoma expresses NG2 immunoreactivity. Br J Ophthalmol 87: 629-632.
13. Naume B, Wiedswang G, Borgen E, et al., (2004): The prognostic value of isolated tumor cells in bone marrow in breast cancer patients: evaluation of morphological categories and the number of clinically significant cells. Clin Cancer Res 10: 3091-3097.
14. Onken MD, Worley LA, Ehlers JP, &, Harbour JW, (2004): Gene expression profiling in uveal melanoma reveals two molecular classes and predicts metastatic death. Cancer Res 64: 7205-7209.
15. Pantel K, Izbicki J, Passlick B, Angstwurm M, Haussinger K, Thetter O, &, Riethmuller G, (1996): Frequency and prognostic significance of isolated tumour cells in bone marrow of patients with non-small-cell lung cancer without overt metastases. Lancet 347: 649-653.
16. Pyrhonen S, (1998): The treatment of metastatic uveal melanoma. Eur J Cancer 34 (Suppl. 3): S27-S30.
17. Suesskind D, Ulmer A, Schiebel U, Fierlbeck G, Spitzer B, Spitzer MS, Bartz-Schmidt KU, &, Grisanti S, (2011): Circulating melanoma cells in peripheral blood of patients with uveal melanoma before and after different therapies and association with prognostic parameters: a pilot study. Acta Ophthalmol 89: 17-24.
18. Thybusch-Bernhardt A, Klomp HJ, Maas T, Kremer B, &, Juhl H, (1999): Immunocytological detection of isolated tumour cells in the bone marrow of malignant melanoma patients: a new method for the detection of minimal residual disease. Eur J Surg Oncol 25: 498-502.
19. Torres V, Triozzi P, Eng C, Tubbs R, Schoenfiled L, Crabb JW, Saunthararajah Y, &, Singh AD, (2011): Circulating tumor cells in uveal melanoma. Future Oncol 7: 101-109.
20. Tveito S, Maelandsmo GM, Hoifodt HK, Rasmussen H, &, Fodstad O, (2007): Specific isolation of disseminated cancer cells: a new method permitting sensitive detection of target molecules of diagnostic and therapeutic value. Clin Exp Metastasis 24: 317-327.
21. Ulmer A, Schmidt-Kittler O, Fischer J, Ellwanger U, Rassner G, Riethmuller G, Fierlbeck G, &, Klein CA, (2004): Immunomagnetic enrichment, genomic characterization, and prognostic impact of circulating melanoma cells. Clin Cancer Res 10: 531-537.